Amplity Health: IQ 2026 Update

A "a leading global medical and commercial partner serving pharmaceutical, biotechnology, medical device, and diagnostics companies worldwide" remains on non-accrual for a 7th quarter in a row. The ultimate outlook is for a significant realized loss. One public BDC is involved.